
A new study has found that Ultraviolet C (UVC) emitting lamps are fast, effective, and safe at inactivating SARS-CoV-2, the …

Sosei Heptares and InveniAI have entered a multi-target AI-powered and GPCR-focused drug discovery collaboration. The two companies will combine InveniAI’s …

The first patient has been dosed in Phase 1/2 trials investigating a new form of cancer therapy, gamma delta TCR …

MIMETAS and Roche have entered into a collaboration to develop human disease models to characterise novel compounds in inflammatory bowel …

The UK has genomically sequenced more than 600,000 positive COVID-19 test, it was announced on Friday. Genomic sequencing plays a …

A strawberry-flavoured generic HIV drug has been distributed in Africa for children and babies living with HIV. The drug, which …

Popular holiday destination, the Portuguese islands of Madeira, have announced that they will allow visitors with any COVID-19 vaccine, even …

BioMed X and Merck have launched a new joint research programme in oncology. The new program will explore the role …

South Korea is in talks with mRNA vaccine makers, including Pfizer-BioNtech and Moderna, to produce up to one billion COVID-19 …

Results released from AstraZeneca’s Phase IIa SATELLITE trial demonstrated that AZD4831, a myeloperoxidase (MPO) inhibitor, achieved pre-specified target engagement in …

The MHRA has granted marketing authorisation to Diurnal’s treatment, Efmody, as treatment of adult and adolescent patients with the rare …

Johnson & Johnson (J&J) has reported that its single-dose Covid-19 vaccine stimulated robust, continued neutralising antibody activity against the Delta …

Up to 5 million Britons planning to travel to Europe may face a travel ban if they have been vaccinated …

The Origin Group has launched a 100% recyclable single-dose sachet which is fully brandable for the health sector. The new …

CureVac’s COVID-19 vaccine has shown only 48% efficacy in its final analysis. This result is only marginally better than the …

The University of Birmingham has partnered with Nonacus to develop a non-invasive test for bladder cancer. The test, which is …

The NHS is planning to offer COVID-19 booster shots to over 50s from September. A third shot of the vaccine …

A study has found that COVID-19 is common in pet cats and dogs whose owners have the disease. Samples were …
PrecisionLife Limited has appointed Ray Pawlicki, previously CIO at Biogen and Novartis, as Executive Chair to the board of directors.Widely …